Sponsor:
Canadian Myeloma Research Group
Code:
NCT05272826
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Iberdomide
Bortezomib
Dexamethasone
Isatuximab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations